← Back to Search

Behavioural Intervention

Pharmacist Management of Paxlovid for COVID-19

N/A
Waitlist Available
Led By Tracy Lieu, MD
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 days after the e-visit
Awards & highlights

Study Summary

This trial will compare two ways of caring for adults with COVID-19, looking at how well they are cared for and how much time & money it costs.

Who is the study for?
This trial is for adults with COVID-19 who request Paxlovid through electronic visits (e-visits) on weekdays from 8:00 am to 4:30 pm during the study period. There are no specific exclusion criteria, so it's open to all patients meeting the inclusion conditions.Check my eligibility
What is being tested?
The study compares two ways of managing e-visit requests for Paxlovid: one where pharmacists handle them and another where a group of adult and family medicine doctors do. It looks at how well each method works by checking counseling quality on drug interactions and how fast prescriptions are given.See study design
What are the potential side effects?
Since this trial focuses on management methods rather than new medications, side effects relate more to potential issues in care like delays or inadequate drug interaction counseling rather than physical health symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 days after the e-visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 days after the e-visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of patients with common potential drug-drug interactions with Paxlovid who received counseling
Secondary outcome measures
Mean hours from e-visit to Paxlovid prescription, among patients who received one
Mean minutes of clinician time per Paxlovid e-visit managed
Personnel cost per Paxlovid e-visit managed
Other outcome measures
Percent of patients rating the quality of care for the Paxlovid e-visit as Excellent or Very Good

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pharmacist CareExperimental Treatment1 Intervention
Pharmacists on a regional team will manage requests for Paxlovid placed by patients via e-visits using a standard protocol.
Group II: Adult and Family Medicine Physician Pool CareActive Control1 Intervention
Adult and family medicine physicians serving in pools will manage requests for Paxlovid placed by patients via e-visits using a standard protocol.

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,110,615 Total Patients Enrolled
Tracy Lieu, MDPrincipal InvestigatorKaiser Permanente
1 Previous Clinical Trials
8,287 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for enrollment in this medical experiment?

"Based on the information hosted on clinicaltrials.gov, this trial is not presently searching for patients. It was first posted on October 9th 2023 and last updated a few days later; however, there are 346 other studies that require participants at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Pharmacist Management of Paxlovid eVisits
2023. "Pharmacist Management of Paxlovid eVisits". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06076863.
~1652 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top